tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AbbVie sees FY25 adjusted EPS $10.38-$10.58 with IPR&D, milestones expense
PremiumThe FlyAbbVie sees FY25 adjusted EPS $10.38-$10.58 with IPR&D, milestones expense
6d ago
AbbVie sees $1.50 per share unfavorable impact in Q3 from milestones expense
Premium
The Fly
AbbVie sees $1.50 per share unfavorable impact in Q3 from milestones expense
6d ago
AbbVie sees Q3 adjusted EPS $1.74-$1.78 with IPR&D, milestones expense
Premium
The Fly
AbbVie sees Q3 adjusted EPS $1.74-$1.78 with IPR&D, milestones expense
6d ago
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
PremiumThe FlyNike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
8d ago
Climb Bio appoints Altschuller as Chief Financial Officer
Premium
The Fly
Climb Bio appoints Altschuller as Chief Financial Officer
9d ago
Bristol Myers, Takeda, Astex to contribute data for AI tool, Reuters says
Premium
The Fly
Bristol Myers, Takeda, Astex to contribute data for AI tool, Reuters says
9d ago
Video: Drugmakers, Paccar, Wayfair reacting to Trump tariff threats
PremiumThe FlyVideo: Drugmakers, Paccar, Wayfair reacting to Trump tariff threats
14d ago
AbbVie submits NDA to FDA for tavapadon for treatment of Parkinson’s disease
Premium
The Fly
AbbVie submits NDA to FDA for tavapadon for treatment of Parkinson’s disease
14d ago
Genmab upgraded to Buy at Guggenheim on royalty revenue upside potential
Premium
The Fly
Genmab upgraded to Buy at Guggenheim on royalty revenue upside potential
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100